Solensia is a drug owned by ZOETIS INC. It is protected by 1 US drug patent filed in 2032. All patents are active. Details of Solensia’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US9328164 | Active | |
About Solensia
Solensia is a drug
owned by ZOETIS INC.
Solensia uses
Frunevetmab as the active
ingredient.
Active Ingredient:
Solensia uses
Frunevetmab as the active ingredient.
Check out other Drugs and Companies using
Frunevetmab ingredient.